Exploration of eJaculatory Anatomy Concept Study (EJAC Study)

January 10, 2023 updated by: Dr Vincent Misrai, Clinique Pasteur

Study of the Biomechanical Anatomy of Ejaculation

Ejaculatory dysfunctions (ED) are an important cause of postoperative dissatisfaction, which lead to a decrease in the intensity of orgasms in 50% of patients. ED is a cause for concern for almost a third of patients who need surgery. Surgical techniques have been developed to limit the occurrence of postoperative ED, but their results remain heterogeneous.

There are very few studies on the biomechanical anatomy of ejaculation. Ejaculation is a complex phenomenon involving different structures and in particular the Veru Montanum. This is the key element in the emission of ejaculate within the prostatic urethra. In addition, there is a structure located in the resection zone of the prostate adenoma. It has therefore been suggested that its resection was a primary source of ED.

A single observational study carried out in by Gil Vernet et al in 1994 evaluated on a single healthy 18-year-old volunteer the ejaculatory mechanism of expulsion using an endorectal probe recording the movements of the prostate, the bladder neck and of the proximal urethra during ejaculation.

A contemporary study of the biomechanics of the ejaculatory expulsion phase could confirm and improve understanding of the involvement of anatomical structures. The results of our study aim to adapt surgical techniques aimed at limiting the risk of postoperative ED.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Toulouse, France
        • Clinique PASTEUR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Affiliated subject or beneficiary of a social security scheme
  • Subject agreeing to participate and having signed the free, informed consent.

Exclusion Criteria:

  • Subject with ejaculatory dysfunction
  • Subject with urinary dysfunction
  • History of urinary or penile surgery
  • Subject with untreated urinary tract infection
  • History of chronic prostatitis
  • Pathology making it impossible to introduce the endorectal probe or the ureteroscope
  • History of colorectal inflammatory disease
  • Recent intake (within 30 days) of drugs known to interfere with ejaculation
  • History of intolerance or allergy to any of the drugs used in the study
  • Subject participating in another clinical study
  • Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study intervention
Transrectal ultrasound and Urethroscopy
Examinations for observation of the pre, per and post-ejaculatory phases
Examinations for observation of the pre, per and post-ejaculatory phases

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peri-urethral muscle contraction
Time Frame: At Day 0
Qualitative description of peri-urethral muscle contraction according to ultrasound videos analysis
At Day 0
Urethra, bladder neck and prostate movements
Time Frame: At Day 0
Qualitative description of movements of the urethra, bladder neck and prostate according to ultrasound videos analysis
At Day 0
Sperm flow within the prostatic urethra
Time Frame: At Day 0
Qualitative description of sperm flow within the prostatic urethra according to ultrasound videos analysis
At Day 0
Spermatic fluid via the ejaculatory ducts
Time Frame: At Day 6
Qualitative description of the expulsion and flow of spermatic fluid via the ejaculatory ducts according to urethroscopy videos analysis
At Day 6
Veru montanum mobility and urethral contraction.
Time Frame: At Day 6
Qualitative description of veru montanum mobility and urethral contraction according to urethroscopy videos analysis
At Day 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Benjamin Pradère, MD, Clinique La Croix du Sud
  • Study Director: Eric Bruguière, MD, Clinique PASTEUR
  • Study Director: Vincent Misraï, MD, Clinique PASTEUR

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2022

Primary Completion (Actual)

January 9, 2023

Study Completion (Actual)

January 9, 2023

Study Registration Dates

First Submitted

November 10, 2022

First Submitted That Met QC Criteria

December 6, 2022

First Posted (Actual)

December 14, 2022

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

January 10, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-A01594-39

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ejaculatory Dysfunction

Clinical Trials on Transrectal ultrasound

3
Subscribe